Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Will Portfolio Strength Benefit PayPal's (PYPL) Q2 Earnings?

Published 07/22/2019, 06:13 AM
Updated 07/09/2023, 06:31 AM

PayPal Holdings, Inc. (NASDAQ:PYPL) is set to report second-quarter 2019 results on Jul 24.

The company’s persistent efforts toward expansion of services portfolio is anticipated to be a catalyst backed by increasing demand for online payments and mobile-commerce services worldwide.

Additionally, the company’s two-sided platform enables it to develop and maintain direct financial relationship with both customers and merchants. The platform connects consumers and merchants facilitating unique end-to-end product experiences to both parties. Merchants are able to keep track of customer behavior and engagement utilizing PayPal’s data.

Further, the platform enables PayPal to maintain a deep and trusted relationship with its growing merchants and consumer base.

All these factors are likely to drive the Total Payment Volume (TPV) in the to-be-reported quarter, which happens to be the key metric for the company’s top line.

TPV in the last reported quarter increased 22% and 25% year over year on spot rate and currency neutral basis, respectively, to $161.5 billion. This was driven by accelerating mobile payments and Venmo, accounting for $66 billion and $21 billion of TPV, respectively.

The Zacks Consensus Estimate for TPV for the second quarter is pegged at $171.7 billion.

Click here to know how the company’s overall second-quarter performance is likely to be.

Robust Portfolio to Aid Growth

PayPal’s strengthening product portfolio is likely to drive the top line in the to-be-reported quarter.

The company’s robust product lines such as Venmo and One Touch are key growth drivers. Both the products are aiding growth in the company’s net new active accounts. Further, these are strengthening customer engagement on PayPal’s platform which is likely to drive total active accounts growth in the quarter under review.

Further, the company launched a new solution, PayPal Commerce Platform, which offers an amalgamation of its technologies, tools, services and financing for businesses of all sizes, and back-end systems like compliance and account authentication.

The service remains a tailwind for PayPal to gain momentum across e-commerce companies, marketplaces and crowdfunding platform by allowing merchants to accept payments and shoppers to checkout via their PayPal accounts globally.

Additionally, the service offers fraud protection services backed by AI and Machine Learning (ML) techniques that positions PayPal well to attract small sellers who do not have similar online shopping infrastructure leveraged by large merchants.

Apart from this, the company unveiled a new solution for the Canadian users which offers up to 75 percent shipping discounts to small businesses. This is likely to aid its presence in Canada.

All these endeavors are likely to drive PayPal’s second-quarter results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Other Stocks to Consider

Currently, PayPal carries a Zacks Rank #2 (Buy).

Some other topr-ranked stock that can be considered in the broader technology sector is Alteryx, Inc. (NYSE:AYX) , Chegg, Inc. (NYSE:CHGG) and Atlassian Corporation PLC (NASDAQ:TEAM) . While Alteryx sports a Zacks Rank #1 (Strong Buy), Chegg and Atlassian carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for Alteryx, Chegg and Atlassian is currently pegged at 13.66%, 30% and 18.28%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report

Chegg, Inc. (CHGG): Free Stock Analysis Report

Atlassian Corporation PLC (TEAM): Free Stock Analysis Report

Alteryx, Inc. (AYX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.